We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
LENZ Therapeutics, Inc.는 미국 내 시력 개선 치료제 개발 및 상업화에 주력하는 상업용 제약 회사입니다. 주요 제품 후보 물질로는 성인 노안 치료를 위한 VIZZ와 LNZ101이 있습니다. LENZ Therapeutics, Inc.는 이전 사명인 Presbyopia Therapies, Inc.에서 2021년 6월 현재의 LENZ Therapeutics, Inc.로 사명을 변경했습니다. 이 회사는 2013년에 설립되었으며, 캘리포니아 솔라나 비치에 본사를 두고 있습니다.